Evaluating the neuroprotective impact of senolytic drugs on human vision

Abstract Glaucoma, a chronic neurodegenerative disease of retinal ganglion cells (RGCs), is a leading cause of irreversible blindness worldwide. Its management currently focuses on lowering intraocular pressure to slow disease progression. However, disease-modifying, neuroprotective treatments for g...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nevin W. El-Nimri, Spencer M. Moore, Linda M. Zangwill, James A. Proudfoot, Robert N. Weinreb, Dorota Skowronska-Krawczyk, Sally L. Baxter
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/c1aad6bcbf894135b674b4437693f52f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!